OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
March 18, 2022
Rush shares his thoughts on how advanced analytics are making their mark on the pharma industry.
March 08, 2022
A new report examining pharma sector exposure makes for sobering reading, especially in US.
February 11, 2022
Obstacles in data exchange remain for industry.
February 09, 2022
Digital disruption is poised to usher in a new era of customer-centricity and efficiency, starting with trials and precision targeting.
Designing an omnichannel artificial intelligence ecosystem that integrates strategies can boost commercial success for pharma.
Spurred on by COVID-19 and companies’ evolving digital maturity, AI looks set to gain a real foothold in pharma’s promotional activities.
January 20, 2022
Providing ultimate value to stakeholders remains key in new style of development.
January 18, 2022
Scott Swain details the most common roadblocks that pharma companies experience when incorporating real-world data (RWD) in regulatory submissions and looks at how they can be addressed.
January 13, 2022
As emerging technologies are identified, C-suites need to determine how they might be pragmatically deployed as solutions to address their pain points, says IBM‘s Dr. Bernard S. Meyerson.
January 11, 2022
The constantly evolving world of data is forcing pharma companies to implement new strategies for improved structure.